Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentRecent Developments of Liposomes as Nanocarriers for Theranostic Applications.Recent Advances in Subunit Vaccine CarriersLiposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and ImmunostimulatorsSynthetic Nanoparticles for Vaccines and ImmunotherapyDesigner lipids for drug delivery: from heads to tails.Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingAntigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding.Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.Biomaterials for nanoparticle vaccine delivery systems.Dynamic nuclear polarization NMR spectroscopy: revealing multiple conformations in lipid-anchored peptide vaccines.Liposomes as vaccine delivery systems: a review of the recent advances.Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.An update on the use of laser technology in skin vaccination.Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.A novel liposome-based nanocarrier loaded with an LPS-dsRNA cocktail for fish innate immune system stimulationUse of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomesPreparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects.Particle-based platforms for malaria vaccines.Enhancing nicotine vaccine immunogenicity with liposomes.Chicken Anti-Campylobacter Vaccine - Comparison of Various Carriers and Routes of Immunization.Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.Liposome-like Nanostructures for Drug Delivery.Novel platform technology for modular mucosal vaccine that protects against streptococcus.Rehmannia glutinosa polysaccharide liposome as a novel strategy for stimulating an efficient immune response and their effects on dendritic cellsMucosal Vaccine Development Based on Liposome Technology.Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes.Working together: interactions between vaccine antigens and adjuvants.Targeted immunomodulation using antigen-conjugated nanoparticles.Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease.Adjuvants and inactivated polio vaccine: a systematic reviewNanoscale assemblies and their biomedical applications.Vaccine design: emerging concepts and renewed optimism.Adjuvants containing natural and synthetic Toll-like receptor 4 ligands.An overview of adjuvant formulations and delivery systems.About supramolecular systems for dynamically probing cells.HIV vaccines: a brief overview.The impact of size on particulate vaccine adjuvants.Nanocarriers: a versatile approach for mucosal vaccine delivery.
P2860
Q24597625-C19C31A1-608B-47D6-954C-DE145AD1B9E1Q26744835-2D295EB0-8772-4FD2-A6F0-E38C67D81DDFQ26750929-D56A3BA6-0933-4DFE-9248-EC3C1E3DA2AEQ26765446-A40687B7-630C-4FC0-A63F-39EC643A6DADQ28085375-1AE31E5E-DA9E-47B5-8DD7-F3007BC15ACFQ30402374-D8DC474A-21C6-4295-960A-15B54FB12872Q30456053-0EA16BCE-C978-4F47-A9D5-F20A8D10E1EFQ33972302-A8EC0FCC-0966-4D8B-A003-FE4744937483Q33994987-84B5BDBB-FAE0-4176-B782-111377CD0BD6Q34345012-4EC06B0F-F8D2-421E-956C-5BCBB67F6FF4Q34371373-EF91B476-5A71-40FC-A1DD-5B0D9D57BEDCQ34418761-9C23D0C9-46B3-4DDA-B09E-722D16A4DE6DQ34871801-53E547FB-7170-4F41-B24E-19FFE5B0F794Q35017651-BFE0F85C-C986-4CBB-B59A-81B90E9DE1C0Q35034311-4B99F011-CD04-46F6-86FA-8750E179FC12Q35034640-A6866AEE-F455-4129-AB9D-A730D35A73C3Q35156323-125AAA1A-8AE3-40AC-86DF-DFBFE2D70467Q35763466-362800C2-5927-4750-A9D6-FAFFA488D5B1Q36396040-4FCB2497-7455-445F-8406-31FC3F9C1C5AQ36569318-3C9F7142-7099-4268-BE52-5E66FFB5A73EQ36915598-85D609E0-92A1-4E62-8A7C-3CEB093E51B9Q37332628-6D3C1D4F-67DB-49F3-B131-1E7464ABE71CQ37424654-973D349D-A370-4B9D-AED3-04D012E2598AQ37504796-255610AA-C94F-46CC-8B71-336A82DA385CQ37515726-DB2E6E4D-945F-4A6C-90FF-337AE0551E06Q37581129-022ED757-1105-49FC-8F0C-14A6F52B96C1Q37584635-672D04A1-542B-4832-932A-1CCAA7CF2A14Q37641676-EF9DAD17-0FEB-43A4-BA7F-6EE1116DC405Q37668409-59E2213A-5E2D-4934-A750-69173C623484Q37705215-97DE6342-C5C8-4233-9828-1409F424CE7BQ38006425-CC950488-C717-4096-B1F1-EBE1A9025D70Q38049900-558BB96C-6FB9-433A-AACB-493056053BEFQ38072847-5B1F8A88-4FA3-4385-8C57-B92054F47BC0Q38087785-E75B5B25-7514-4B4E-B87E-AADA6D54EA56Q38124063-9AE7BAAB-4D84-4822-931B-CFB09C454026Q38126953-D355270B-46AE-4117-A010-B4351DDF334EQ38200457-57A4C1BF-1197-4FBE-A81D-8DD43F3477A2Q38210557-6C9F08C1-3DEF-4939-A820-5C1C2730C60FQ38296080-193EBA7D-2010-41DB-808E-3FF3D59BF65AQ38358876-A1CE4AD1-723E-470E-BF7C-283D9A6CF002
P2860
Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Design considerations for lipo ...... o liposome associated antigens
@ast
Design considerations for lipo ...... o liposome associated antigens
@en
type
label
Design considerations for lipo ...... o liposome associated antigens
@ast
Design considerations for lipo ...... o liposome associated antigens
@en
prefLabel
Design considerations for lipo ...... o liposome associated antigens
@ast
Design considerations for lipo ...... o liposome associated antigens
@en
P2093
P2860
P1433
P1476
Design considerations for lipo ...... o liposome associated antigens
@en
P2093
Aaron N Endsley
Douglas S Watson
Leaf Huang
P2860
P304
P356
10.1016/J.VACCINE.2012.01.070
P407
P577
2012-02-02T00:00:00Z